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Development of accurate risk assessment
procedures and models is a complex, data-inten-
sive task often impeded by a paucity of data. To
promote the development of models and meth-
ods well founded on experimental research, a
program is needed to ensure sufﬁcient coordina-
tion between appropriate data generation and
data use. Toward this goal, and as part of the
mixtures program at the Agency for Toxic
Substances and Disease Registry (ATSDR),
well-designed, short-term experimental research
studies are being supported to elucidate toxico-
logic mechanisms to better understand the mol-
ecular toxicology of chemicals, particularly their
mechanisms of interaction, and to establish
qualitative and quantitative models. The goal of
the research component of the mixtures pro-
gram is to bring together laboratory investiga-
tors, model developers, and risk assessors to
ensure that experimental designs addressing
existing data gaps will be employed. 
Because humans are exposed to several
chemicals and their combinations, toxicity
testing has become the cornerstone of chemi-
cal hazard assessment. Although ideally it is
desirable to test in whole-animal models, the
number of environmental chemicals and their
possible combinations are too large to be ade-
quately evaluated in the test systems used in
classic toxicity testing procedures and proto-
cols. Hence, several in vitro assays are being
used by the scientiﬁc community to screen for
biologic activity, understand the mode and
mechanisms of action of chemical toxicity in
target organs, and estimate the joint toxicity
of chemical mixtures. However, the results of 
in vitro studies should be carefully analyzed to
determine the plausibility of biologic activity
in the whole-animal systems, taking into con-
sideration the biologic and pharmacokinetic
processes important to the in vivo expression
of toxicity.
For about a decade, ATSDR has supported
the use of alternative methods for laboratory
testing and the development of computational
tools to augment knowledge in the areas of
hazard identification and toxicity evaluation
(1). In 1994 ATSDR hosted an international
symposium of experts in computational meth-
ods that led to the establishment of a state-of-
the art computational toxicology laboratory
(2). One of the activities of this laboratory is
the agency’s mixtures program, which consists
of identification of environmental mixtures,
joint toxicity assessment, and experimental
testing (3). Through the mixtures program,
the agency has supported in vitro and limited
in vivo toxicity testing targeted to ﬁll data gaps
needed to support physiologically based phar-
macokinetic modeling designed to improve
our understanding of the toxicity and health
effects of chemical mixtures (1).
In this article, we review results from two
different studies conducted to evaluate the
biologic activity of persistent pollutants iden-
tified in environmental media at hazardous
waste sites. The ﬁrst study measured the abil-
ity of six high-priority persistent organochlo-
rine pesticides and defined mixtures to
modulate transcriptional activation of an
estrogen-responsive reporter gene in trans-
fected HeLa cells. In the second study, four
high-priority metals and a mixture were
tested for their ability to induce 13 different
gene promoters in a battery of recombinant
HepG2 cells (Table 1). The organic pollutants
and their Comprehensive Environmental
Response, Compensation and Liability Act
of 1980 (or Superfund) (Public Law 96510,
11 December 1980) priority rankings (indi-
cated in square brackets) are p,p´-DDT [13],
p,p´-DDD [26], p,p´-DDE [22], aldrin [25],
dieldrin [18], and endrin [39]. The metals
studied were arsenic (As) [1], lead (Pb) [2],
cadmium (Cd) [7], Cr(VI) [16], and Cr(III)
[69]. The ranking of these chemicals is
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As part of its mixtures program, the Agency for Toxic Substances and Disease Registry (ATSDR)
supports in vitro and limited in vivo toxicity testing to further our understanding of the toxicity
and health effects of chemical mixtures. There are increasing concerns that environmental chemi-
cals adversely affect the health of humans and wildlife. These concerns have been augmented by
the realization that exposure to chemicals often occurs to mixtures of these chemicals that may
exhibit complex synergistic or antagonistic interactions. To address such concerns, we have con-
ducted two studies with techniques that are being used increasingly in experimental toxicology. In
the ﬁrst study, six organochlorine pesticides (4,4´-DDT, 4,4´-DDD, 4,4´-DDE, aldrin, dieldrin,
or endrin) were selected from the ATSDR Comprehensive Environmental Response,
Compensation and Liability Act of 1980 (or Superfund) priority list and tested for their ability to
modulate transcriptional activation of an estrogen-responsive reporter gene in transfected HeLa
cells. In these assays, HeLa cells cotransfected with an expression vector encoding estrogen recep-
tor and an estrogen-responsive chloramphenicol acetyltransferase (CAT) reporter plasmid were
dosed with and without selected environmental chemicals either individually or in deﬁned combi-
nations. Estradiol consistently elicited 10- to 23-fold dose-dependent inductions in this assay. By
contrast, all six of the organochlorine pesticides showed no detectable dose-related response when
tested either individually or in binary combinations. Thus, these chemicals as binary mixtures do
not exhibit any additional estrogenicity at the levels tested in these assays. In the second study,
arsenic [As(V)], cadmium [Cd(II)], chromium [Cr(III, VI)], and lead [Pb(II)] were tested in a
commercially developed assay system, CAT–Tox (L), to identify metal-responsive promoters and
to determine whether the pattern of gene expression changed with a mixture of these metals. This
assay employs a battery of recombinant HepG2 cell lines to test the transcriptional activation
capacity of xenobiotics in any of 13 different signal-transduction pathways. Singly, As(V), Cd(II),
Cr(III, VI), and Pb(II) produced complex induction proﬁles in these assays. However, no evidence
of synergistic activity was detected with a mixture of Cd(II), Cr(III), and Pb(II). These results
have shown metal activation of gene expression through several previously unreported signal-
transduction pathways and thus suggest new directions for future studies into their biochemical
mechanisms of toxicity. In conclusion, the in vitro methods used in these studies provide insights
into complex interactions that occur in cellular systems and could be used to identify biomarkers
of exposure to other environmental chemical mixtures. Key words: aldrin, arsenic, cadmium,
chemical mixtures, chromium, 4,4´-DDD, 4,4´-DDE, 4,4´-DDT, dieldrin, endrin, endocrine
disruptors, estrogen, lead. Environ Health Perspect 110(suppl 6):947–956 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-6/947-956mumtaz/abstract.html
Gene Induction Studies and Toxicity of Chemical Mixtures
M.M. Mumtaz,1 D.B. Tully,2 H.A. El-Masri,1 and C.T. De Rosa1
1Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Atlanta, Georgia, USA; 2Ofﬁce of
Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA948 VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 • Environmental Health Perspectives
determined on the basis of their frequency of
occurrence, toxicity, and potential for human
exposure (4).
Materials and Methods
Experimental Procedures
Chemicals used in these studies, their CAS
numbers, and purity are given in Table 2.
Details of the experiments and procedures
have been published (5,6). Brieﬂy, in the ﬁrst
series of experiments, dosing solutions were
prepared by dissolving the neat chemicals in
95% ethanol followed by 10-fold serial dilu-
tions. The concentration of ethanol was kept
constant at all doses of pesticides, so the cells
were consistently exposed only to 0.1%
ethanol. HeLa cells, a transformed human
ovarian carcinoma cell line, were seeded 
(~6 × 105 cells/well) in 6-well microtiter
plates, approximately 40–60% confluent at
the time of seeding. The HeLa cell transfec-
tion system used in these assays employed an
estrogen-responsive chloramphenicol acetyl-
transferase (CAT) reporter vector regulated
by a promoter containing two contiguous
copies of an estrogen response element. These
assays were previously shown to give a robust
response to 17β-estradiol (E2) and to give
measurable responses to weak environmental
estrogens such as 2-2-bis(p-hydroxyphenyl)-
1,1,1-trichloroethylene, nonylphenol, and
o,p´-DDT (7). The duration of chemical
exposures was 18 hr in all cases, and a broad
range of pesticide doses (0, 0.001, 0.01, 0.1,
1.0, and 10 µM) was chosen to mimic serum
levels measured in previous experiments with
mice and for comparability with earlier work
using this assay system (7) and other pub-
lished reports (8,9). Triplicate cell cultures
were dosed at each concentration of hor-
mone, pesticide, or pesticide mixture, and the
cells were harvested 18 hr after dosing. After
cell harvesting, detergent cell lysates were
either quick-frozen at –80°C, or aliquots were
assayed immediately for CAT protein using
the CAT–ELISA (enzyme-linked immuno-
sorbent assay) kit (Boehringer Mannheim,
Indianapolis, IN, USA) according to the
manufacturer’s instructions. Additional
aliquots of each cell lysate were subsequently
assayed to determine total protein concentra-
tion using the BioRad Protein Assay Reagent
(BioRad, Hercules, CA, USA) (10). The
amount of CAT protein measured in the
CAT–ELISA assay for each cell lysate was
normalized to that well’s amount of total pro-
tein, and the results were tabulated as
nanograms CAT per milligram protein.
In the second series of experiments,
appropriate amounts of metal salt were added
to the 1 mM humic acid (HA) stock to
obtain the desired metal concentration. The
HA or metal–HA stocks were then diluted
10-fold into cell culture medium, which was
serially diluted to obtain the experimental
doses chosen on the basis of preliminary
dose–range-finding experiments. HepG2
cells, a human hepatoma cell line, and the 13
recombinant cell lines derived from them
(Xenometrix, Boulder, CO, USA) (11) were
seeded (~5.5 × 104 cells/well) in all wells of a
single row of a 96-well microtiter plate, one
row per recombinant cell line; the cells were
approximately 40–60% conﬂuent at the time
of seeding. Cell viability was assayed on
each plate at each dose using the 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetra-
zolium bromide (MTT) assay (12). Thus,
two microtiter plates were required to
accommodate all 13 recombinant cell lines
plus the wild-type HepG2 cell line while
allowing two columns per treatment.
Although this conﬁguration comprises a sin-
gle CAT–Tox (L) assay, these experiments
were always done in triplicate using three
such pairs of microtiter plates. Additionally,
independent replicates of each experiment
were performed on different dates. Cells
were incubated at 37°C and 5% CO2 for
48–72 hr before exposure to chemical
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Table 1. Different promoters and their functional deﬁnitions.
Abbreviation Gene promoter name Function Implications
CYP 1A1 Cytochrome P450 1A1 Ah receptor–responsive promoter (35,36) Aryl hydrocarbons
GST Ya Glutathione S-transferase Ya Contains both antioxidant and Ah response Aryl hydrocarbons; oxidative 
elements (30,31) stress
XRE Xenobiotic response element Two contiguous oligonucleotide copies of Ah Aryl hydrocarbons
receptor binding site from the Cyp 1A1
promoter (36)
hMTIIA Human metallothionein II A Heavy metal–responsive promoter (26, 27) Heavy metal stress
FOS c-fos immediate early oncogene Responds to mitogens and DNA damage (32) DNA damage; oxidative stress
NFκBRE Nuclear factor kappa B response element Immune inﬂammatory and Inﬂammatory response; oxidative
acute phase response (34,53) stress
HSP70 70-kDa Heat shock protein Induced by heat, heavy metals, protein denaturants Stress response
(54,55)
CRE Cyclic AMP response element Cyclic AMP receptor–responsive promoter (65) cAMP
p53RE Tumor suppressor p53 response element Responds to DNA damage (37,39) DNA damage; oxidative stress
RARE Retinoic acid response element Responds to retinoic acid and analogs (67) Retinoic acid
GADD153 153-kDa Growth arrest Responds to DNA damage (40,44) DNA damage
and DNA damage
GADD45 45-kDa Growth arrest and DNA damage Responds to DNA damage (64) DNA damage
GRP78 78-kDa Glucose-regulated protein Responds to protein deanaturation and DNA Protein denaturation;DNA
damage (43) damage
Table 2. Organochlorine pesticides and inorganic chemicals used in these studies.
Common or
trade name Chemical name CAS no. Purity (%)
Estradiol 17β-Estradiol 50-28-2 99+
p,p´-DDT Bis(p-chlorophenyl)-2,2,2-trichloroethane 50-29-3 98
p,p´-DDD Dichlorodiphenyldichloroethane 72-54-8 99
p,p´-DDE Dichlorodiphenyldichloroethylene 72-55-9 99
Aldrin 1,4:5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro-
1,4,4a,5,8,8a-hexahydro-, (1a,4a,4ab,5a,8a,8ab)- 309-00-2 98
Dieldrin 2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-
1a,2,2a,3,6,6a,7,7a-octahydro-, (1aa,2b,2aa,3b,6b,6aa,7b,7aa)- 60-57-1 98
Endrin 2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro- 72-20-8 98
1a,2,2a,3,6,6a,7,7a-octahydro-, (1aa,2b,2ab,3a,6a,6ab,7b,7aa)-
Arsenic (V) Ammonium arsenate 7784-44-3 95+
Cadmium (II) Cadmium acetate dihydrate 5643-04-4 98
Chromium (VI) Potassium dichromate 7778-50-9 99
Chromium (III) Chromium acetate 1066-30-4 99
Lead (II) Lead nitrate 18256-98-9 99+
Humic acid 1415-93-6 Technical
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treatments. The duration of chemical expo-
sures was 48 hr. In all experiments where cells
were treated with Cr(VI) in HA, special care
was taken to use freshly prepared stocks,
because HA reportedly causes chemical reduc-
tion of Cr(VI) to Cr(III) (13,14). Specific
details of chemical treatments for each metal
or mixture are given in Table 3.
Because there has been increasing concern
about the potential for synergistic increases in
toxicity stemming from exposure to mixtures
of chemicals, and because mixtures of these
metals commonly occur as pollutants at haz-
ardous waste sites on the U.S. Environmental
Protection Agency’s National Priorities List
(15), we wanted to test combinations of some
of these metals in the CAT–Tox (L) assays. To
increase the likelihood of detecting potential
synergistic effects, we decreased the top con-
centration of Cd(II) in the mixture to 7.5 µM,
half the high dose used when testing Cd alone,
so the high dose of the mixture contained
7.5 µM Cd(II), 750 µM Cr(III), and 100 µM
Pb(II) in 100 µM HA.
After the treatment period, all the cells,
except one row containing the wild-type
HepG2 cell line reserved for cell viability
assays, were lysed with 100 µL detergent lysis
buffer. Ten-microliter pooled lysate aliquots
from each pair of identically dosed cells were
assayed to determine total protein concentra-
tion using BioRad Protein Assay Reagent
(BioRad) according to the manufacturer’s
instructions (10). The amount of CAT pro-
tein in each lysate was then determined using
a sandwich ELISA assay with CAT–ELISA
reagents from Boehringer-Mannheim, as pre-
viously described (11). Transcriptional activi-
ties were calculated by dividing the amount
of specific CAT protein measured in the
CAT–ELISA assay for each cell lysate by the
corresponding amount of total protein.
Data Analysis
In the first series of experiments, the mean
and standard error were calculated for the
amount of CAT protein measured in three
independent experiments, each containing
triplicate measurements at each dose; the
results were plotted as bar graphs. Data were
further analyzed with Student t-test, and the
signiﬁcance level was ascertained at p < 0.05.
For the second series of experiments, after
logarithmic transformation of the transcrip-
tional activities to stabilize their variances, a
separate analysis of variance (ANOVA) (16)
was performed for each combination of chemi-
cal and cell line. Within each ANOVA, one-
sided and two-sided Dunnett’s tests (17,18)
were used to assess which treatment groups
showed transcriptional activity significantly
different from the control group at the α =
0.05 level. The ratio of the transcriptional
activity for a dose group versus the control
group, i.e., [CAT] (test sample)/[CAT] (zero
dose control), is called the fold induction,
which represents the dose-speciﬁc increase in
activity induced by the treatment relative to
baseline. In each experiment, the fold induc-
tions for the three replicates were averaged.
The means of these averages for data from
experiments performed on different dates were
calculated and plotted in the figures as bars,
with their standard errors shown by lines
extending above the bars.
Results
Figure 1A shows the results of testing 
p,p´-DDT, p,p´-DDD, and p,p´-DDE in indi-
vidual assays. Estradiol produced a dose-
responsive transcriptional induction proﬁle in
which 0.01 nM E2 yielded approximately 3-
fold induction over the vehicle control, 0.1 nM
E2 gave a 4-fold induction, and 1.0 nM E2 gave
maximal induction of approximately 10-fold.
In contrast, none of the three DDT isomers—
p,p´-DDT, p,p´-DDD, or p,p´-DDE—showed
appreciable induction over the background lev-
els of the vehicle controls at any of the five
doses tested. The small apparent increases in
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Table 3. Final doses of metals and metal mixtures used.
Single chemical concentrations (µM)
HA As(V) Pb(II) Cd(II) Cr(III) Cr(VI)
00 0 0 0 0
6.25 50 6.25 1.25 50 0.625
12.5 100 12.5 2.5 150 1.25
25 150 25 5 250 2.5
50 200 50 10 500 5.0
100 250 100 15 750 10
Mixture component concentrations (µM)
Percent Cd(II) Pb(II) Cr(III)
00 0 0
0.63 0.47 6.25 47
1.25 0.94 12.5 94
2.5 1.87 25 187
5.0 3.75 50 375
10.0 7.50 100 750
Figure 1. Transcriptional activation of an estrogen-responsive CAT reporter gene by p,p´-DDT, p,p´-DDE, and p,p´-DDD. HeLa cells cotransfected with the
estrogen receptor expression vector pRSVmER and an estrogen-responsive CAT reporter plasmid, pERET81CAT, were dosed for 18 hr with vehicle, with
0.01–1.0 nM 17β-estradiol, or with 0–10 µM p,p´-DDT, p,p´-DDD, or p,p´-DDE (A). In parallel experiments, transfected cells were dosed with vehicle, with
0.01–1.0 nM 17β-estradiol, or with equimolar mixtures of p,p´-DDT + p,p´-DDD, p,p´-DDT + p,p´-DDE, or p,p´-DDD + p,p´-DDE (B). The results shown represent the
mean of three independent experiments.
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A Btranscriptional activation of the estrogen-
responsive CAT reporter shown by p,p´-DDE
were not statistically signiﬁcant and not partic-
ularly dose responsive. Although the apparent
decrease in transcriptional induction below
background levels seen with 10 µM p,p´-DDD
was significant at the α = 0.05 level, this
decrease almost certainly related to the high
degree of toxicity of this compound, where
visual inspection revealed that 50–70% of the
cells were killed at the highest dose. A smaller
decrease in transcriptional activation at 0.1 µM
p,p´-DDT was not statistically signiﬁcant, and
no decrease in cell number was found at this or
any other dose of p,p´-DDT. Thus, none of the
three DDT isomers tested individually showed
any significant evidence of estrogenicity in
these assays.
Similar results were obtained when the
three DDT isomers were tested in equimolar
binary combinations, as shown in Figure 1B.
In the combination assays, the pesticide con-
centration shown represents the sum of the
concentrations of the two components of the
mixture, e.g., 10 µM p,p´-DDT + p,p´-DDD
(equimolar) means 5 µM p,p´-DDT + 5 µM
p,p´-DDD. None of the combinations—p,p´-
DDT + p,p´-DDD, p,p´-DDT + p,p´-DDE,
or p,p´-DDD + p,p´-DDE— showed any sig-
nificant estrogenic activity above the vehicle
control background levels. This was true,
despite the fact the estradiol-positive controls
in these experiments yielded a robust induc-
tion profile, showing that these cells were
fully capable of responding to an estrogenic
stimulus. Again, where p,p´-DDD was pre-
sent in the mixture, increased toxicity and
noticeable cell loss were observed at the high-
est dose, but the small decrease in CAT
production measured in this case was not
statistically signiﬁcant.
The results of testing aldrin, dieldrin, and
endrin are shown in Figure 2. Figure 2A shows
the results of testing these three pesticides indi-
vidually. The estradiol-positive controls again
produced dose-responsive transcriptional
responses. However, neither aldrin, dieldrin,
nor endrin showed any signiﬁcant estrogenic
activity at any of the five doses tested. This
occurred in experiments where the estradiol-
positive controls gave dose-responsive
inductions up to 16-fold at 1 nM estradiol.
When aldrin, dieldrin, and endrin were
tested in equimolar binary combinations
(Figure 2B), no activity above the zero-dose
controls was seen for any of the three mix-
tures. Thus, these three cyclodiene pesticides
showed no evidence of estrogenic activity
individually, and clearly showed no synergis-
tic enhancement of estrogenic activity in any
of the combinations tested.
In the second study (Figure 3), HA
alone produced a moderate, dose-dependent
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Figure 2. Transcriptional activation of an estrogen-responsive CAT reporter by aldrin, dieldrin, and endrin. Twenty-four hours after cotransfection with the
estrogen receptor expression vector pRSVmER and the estrogen-responsive CAT reporter plasmid pERET81CAT, HeLa cells were dosed for 18 hr with vehicle,
with 0.01–1.0 nM 17β-estradiol, or with 0–10 µM aldrin, dieldrin, or endrin (A). In parallel experiments (control), transfected cells were dosed with vehicle, with
0.01–1.0 nM 17β-estradiol, or with equimolar mixtures of aldrin + dieldrin, aldrin + endrin, or dieldrin + endrin (B). The results shown represent the mean of
three independent experiments.
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Figure 3. Proﬁle of transcriptional induction of selected stress-response promoters in transgenic HepG2
cells dosed for 48 hr with 0–100 µM HA. The results shown represent the mean of four independent
experiments for which fold inductions from three replicate assays were averaged. See Table 3 for details
of dosing.
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ninduction of the xenobiotic response element
(XRE) promoter up to 5-fold at the highest
concentration (100 µM). HA-induced
increases in transcription of the cytochrome
P450 1A1 (CYP1A1), glutathione S-trans-
ferase Ya (GST Ya), and tumor suppressor
p53 response element (p53RE) promoters
were all 2-fold or less and were significant
only at the highest dose. HA had relatively
little effect on cell viability at all doses tested
(6). These results show that HA could be
employed as a carrier for the metals without
either seriously compromising the integrity of
the cultured cells or producing a confounding
pattern of reporter gene inductions.
As(V) in HA (Figure 4) produced a
complex profile of inductions among the
nine promoters. There was consistently
strong dose-dependent induction of the
human metallothionein II A (hMTIIA) pro-
moter at all doses tested, up to 70-fold at the
highest dose (250 µM). As also showed a
strong dose-dependent induction of the 70-
kDa heat shock protein (HSP70) promoter
up to 23-fold at the high dose (250 µM).
Strong transcriptional activation of the 
GST Ya promoter, with an average 52-fold
increase in the high-dose group (250 µM)
was observed; however, the fold induction
values varied greatly. In addition to the two
signature inductions, hMTIIA and HSP70,
As also induced expression of the c-fos imme-
diate early oncogene (FOS), XRE, and
nuclear factor kappa B response element
(NFκBRE) promoters at more moderate, but
still dose-dependent levels, up to 12-, 10-,
and 9-fold, respectively, at the high dose
(250 µM). As produced a nearly linear
decrease in cell viability over the range of
doses tested, with viability decreasing to 69%
at the highest dose (6).
Figure 5 shows that Pb(II) in HA induced
the GST Ya promoter most strongly, with
dose-related responses up to 16-fold at the
highest dose (100 µM). However, as with
As(V), these responses were highly variable.
Less variability was seen in the responses from
the XRE promoter, which gave a dose-depen-
dent profile of inductions of similar magni-
tude, ranging up to 14-fold at the highest dose.
Pb also caused moderate dose-related induc-
tion of the hMTIIA promoter up to 7-fold and
smaller though still dose-related inductions of
the 78-kDa glucose-regulated protein (GRP
78) and CYP1A1 promoters (3-fold) at the
high dose. Pb had only moderate effects on cell
viability, decreasing cell viability to 84% at the
highest dose (6).
Cd in HA (Figure 6) showed greatest
induction of hMTIIA, with dose-responsive
increases throughout the range of doses tested
(1–15 µM) up to 77-fold at the highest dose.
Cd induction of gene expression from the
GST Ya promoter was more moderate than
Environmental Health Perspectives • VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 951
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Figure 4. Transcriptional induction profile in transgenic HepG2 cells dosed with 0–250 µM ammonium
arsenate in HA for 48 hr. The results shown represent the mean of three independent experiments for
which fold inductions from three replicate assays were averaged. See Table 3 for details of dosing.
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Figure 5. Profile of transcriptional induction for transgenic HepG2 cells dosed with 0–100 µM Pb(II) in
HA for 48 hr. The results shown represent the mean of three independent experiments for which fold
inductions from three replicate assays were averaged. See Table 3 for details of dosing.
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1with As, giving induction values up to 14-fold
at the highest dose (15 µM) but again was
highly variable among the three independent
experiments. Unlike As, however, Cd pro-
duced only moderate dose-dependent induc-
tions of the HSP70 promoter, up to only
4-fold at the highest dose (15 µM), but gave a
more striking proﬁle of inductions of the XRE
promoter, up to 32-fold at the high dose. In
further contrast to As, Cd also caused strong
dose-dependent induction of the CYP 1A1
promoter, up to 15-fold, but gave only small
inductions of the NFκBRE and FOS promot-
ers, up to 4- and 3-fold, respectively, at the
high dose (15 µM). Cd produced a nearly
linear decrease in cell viability down to 62% at
the highest dose (6).
In marked contrast to the other metals
tested, Cr(III) in HA failed to produce strik-
ing inductions among any of the promoters
(Figure 7). This was true despite the use of
very high doses of Cr(III) up to 750 µM. It is
also noteworthy that, in contrast to the As,
Pb, and Cd results, GST Ya was only slightly
induced. The very small fold induction values
seen for the cyclic AMP response element
(CRE) (3- fold), FOS (2-fold), 153-kDa
growth arrest and DNA damage (GADD153)
(2-fold), and XRE (2-fold) promoters were
signiﬁcant only at the highest (750 µM) dose
and showed no indication of dose dependence
at lower doses. Cr(III) did cause an approxi-
mately linear decrease in cell viability down to
62% at the highest dose (6). Cr(VI), however,
produced a strikingly different induction pro-
file (Figure 8). At 10 µM, Cr(VI) produced
greater than 2-fold induction of all the pro-
moters assayed, although several promoter
inductions were signiﬁcant only at the highest
dose [CYP1A1, GST Ya, hMTIIA, NFκBRE,
GADD153, and GRP78]. The most striking
dose-dependent inductions were the p53RE
and FOS promoters: up to 44- and 38-fold,
respectively, at the high dose. In addition to
these two prominent responses, Cr(VI) also
produced dose-related fold inductions of the
XRE (13-fold), 45-kDa growth arrest and
DNA damage (GADD45) (10-fold), HSP70
(8-fold), and CRE (7-fold) promoters, as well
as inductions of NFκBRE (13-fold), CYP1A1
(8-fold), GADD153 (7-fold), and GST Ya (6-
fold) that were signiﬁcant only at the highest
dose. Cr(VI) was highly cytotoxic, and at
doses nearly two orders of magnitude lower
than were used with Cr(III) caused a very
sharp decline in cell viability (6). At any dose
greater than 10 µM, essentially all the cells
were killed.
The only prominent response from
treating the cells with a mixture of 7.5 µM
Cd(II), 750 µM Cr(III), and 100 µM Pb(II) in
100 µM HA was associated with the hMTIIA
promoter, which showed a dose-related proﬁle
with a 50-fold induction at the highest dose
952 VOLUME 110 | SUPPLEMENT 6 | DECEMBER 2002 • Environmental Health Perspectives
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Figure 6. Proﬁle of transcriptional induction and cell viability for transgenic HepG2 cells dosed with 0–15 µM
Cd(II) in HA for 48 hr. The results shown represent the mean of three independent experiments for which
fold inductions from three replicate assays were averaged. See Table 3 for details of dosing.
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Figure 7. Proﬁle of transcriptional induction for transgenic HepG2 cells dosed with 0–750 µM Cr(III) acetate
in HA for 48 hr. The results shown represent the mean of three independent experiments for which fold
inductions from three replicate assays were averaged. See Table 3 for details of dosing.
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1(Figure 9). There was a small, apparently dose-
related induction of the XRE promoter 
(4-fold) at the high dose but only the high
dose was signiﬁcant. There were also small fold
inductions (2-fold) of the CYP1A1, FOS,
NFκBRE, HSP70, and p53RE promoters that
were statistically significant only at the high
dose. The apparent induction of the GST Ya
promoter (2-fold) was not statistically
significant. This mixture of metals had no
appreciable effect on the viability of the cells
across the range of doses tested (6).
Discussion
Existing literature offers mixed reports
regarding possible estrogenic activity of the
pesticides studied. p,p´-DDT has been
reported to be weakly estrogenic in various 
in vitro assays (19–21). However, the widely
reported estrogenic activity of technical-grade
DDT most likely derives from its lesser com-
ponent o,p´-DDT, whereas other studies sug-
gest possible species differences in the
estrogenicity of DDT (8). Its two metabo-
lites, p,p´-DDD and p,p´-DDE have been
reported to exhibit different effects in differ-
ent model systems (20,22). However, consis-
tent with our results, the bulk of evidence
suggests that p,p´-DDE is nonestrogenic or
very weakly estrogenic.
There are also mixed reports of
endocrine activity for the cyclodiene pesti-
cides. The potential estrogenic activity of
aldrin remains unclear. It has been reported
to yield uterotrophic effects and increased
endometrial proliferation at very high doses
in some studies but in others showed no
detectable uterotrophic activity even at
1,000 mg/kg (23,24). Similarly, dieldrin has
been reported to be weakly estrogenic (19)
or nonuterotrophic alone (24) or in combi-
nation with endosulfan (25). Additionally,
dieldrin alone or mixed with toxaphene did
not induce significant increases in any of
three estrogen-responsive end points (9).
Thus, in addition to our findings, a sizable
body of evidence suggests that dieldrin is not
estrogenic. No previous reports assessing the
potential estrogenic activity of endrin have
been found.
Thus, there was virtually no detectable
estrogenic activity for any of the six
organochlorines tested singly. However, in each
experiment, the estradiol-positive controls con-
sistently produced dose-responsive CAT induc-
tion proﬁles. Given the essentially undetectable
levels of activity shown by these pesticides
tested individually, it is not surprising that
estrogenic activity was not detectable with their
equimolar binary combinations. Furthermore,
it is clear that there were no synergistic interac-
tions among combinations of these pesticides.
The results with As(V) agree with earlier
reports demonstrating that the hMTIIA and
Chemical Mixtures • Toxicity of chemical mixtures
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Figure 8. Proﬁle of transcriptional induction for transgenic HepG2 cells dosed with 0–10 µM Cr(VI) in HA for
48 hr. The results shown represent the mean of two independent experiments for which fold inductions
from three replicate assays were averaged. See Table 3 for details of dosing.
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Figure 9. Profile of transcriptional induction for transgenic HepG2 cells dosed for 48 hr with 0–10% of a
mixture containing Cd(II), Cr(III), and PB(II) in 1.0 mM HA. The results shown represent the mean of two
independent experiments for which fold inductions from three replicate assays were averaged. The
details of dosing are given in Table 3.
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50
25HSP70 promoters are characteristically
induced by metals, including zinc, Cd, and
As (26–29). The prominent, though variable,
induction of the GST Ya promoter by arsen-
ate in HA is a novel finding. The GST Ya
promoter contains an antioxidant-response
element in addition to an XRE, and its
induction may signal a cellular response to
oxidative stress (30,31). This possibility is
substantiated by coordinate induction of the
FOS and NFκBRE promoters, which are also
associated with oxidative stress responses
(32–34). The dose-dependent induction of
the XRE-regulated reporter may be partly
attributable to a low level of aryl hydrocar-
bons in the HA carrier (35,36). However, the
levels of induction from this promoter were
nearly 2-fold higher after treatment with arse-
nate in HA than those seen with HA alone
(Figure 3). This suggests that arsenate has a
direct or indirect effect on the XRE pro-
moter. Finally, the results showing the coor-
dinate dose-responsive induction of p53RE
and GADD153 along with FOS, discussed
previously, is strongly indicative of a cellular
response both to DNA damage and to oxida-
tive stress (37–40). Thus, arsenate exposure
subjects these cells to toxic stresses involving
an array of responses acting through several
different and previously unreported signal-
transduction pathways, including GST Ya,
FOS, XRE, NFκBRE, GADD153, p53RE,
and CRE. Knowledge of these additional 
signal-transduction pathways may offer new
insights into the biochemical mechanisms of
the toxicology and carcinogenicity of As.
The moderate induction of the hMTIIA
and GRP78 promoters by Pb(II) (Figure 5)
is consistent with earlier reports (41,42). Pb
induction of the GRP78 promoter is sugges-
tive of protein structural perturbations (43),
whereas its induction of the GADD153 pro-
moter suggests a cellular response to DNA
damage (40,44,45). Both of these responses
are suggestive of a cellular response to oxida-
tive damage. Although induction of the
XRE, GST Ya, and CYP1A1 promoters is
typically suggestive of the presence of aryl
hydrocarbons (35,36) because there was
greater induction of these promoters in the
presence of Pb in HA than with HA alone
suggests that the induction of these three
promoters must be at least partly attribut-
able to Pb. Further work will be needed to
elucidate what role Pb may play in inducing
expression of these genes. The demonstra-
tion of the Pb-induced expression of GST
Ya, XRE, CYP1A1, and GADD153 offers
new insights into the mechanisms of toxicity
and carcinogenicity of Pb and suggests
potential new directions for further study on
the biologic effects of Pb.
The gene expression proﬁle for Cd in HA
in these assays (Figure 6) was similar in several
ways to the results seen with As (Figure 4),
suggesting possible parallels in the biochemical
mechanisms of toxicity for these two metals.
The very strong dose-dependent induction of
the hMTIIA-regulated reporter by Cd is con-
sistent with previous reports (26,46,47). In
addition, like As, Cd induced dose-responsive
CAT gene expression from the GST Ya and
XRE promoter constructs, though the relative
levels of induction were different. By contrast
with As, however, Cd induced dose-dependent
expression of the CYP1A1 promoter–regulated
reporter. Induction of the CYP1A1, GST Ya,
and XRE cluster of promoters is typically sug-
gestive of the presence of aryl hydrocarbons
(30,35,36,48). However, as noted previously
with As(V), Cd(II), and Pb(II), the magnitude
of induction was much greater with Cd in HA
than with HA alone (Figure 3), suggesting that
Cd must account for much of the observed
expression from these promoters. We know of
no previous work describing Cd induction of
gene expression through the CYP1A1 or XRE
promoter. There are, however, earlier reports
indicating that Cd exposure increases the con-
centration of reduced glutathione in various
mammalian cell lines (49,50) and induces
expression of γ-glutamylcysteine synthase (51),
an enzyme central to the metabolic pathway
for glutathione synthesis. Because GST plays a
critical role in the conjugation of reduced glu-
tathione with electrophilic xenobiotics (52),
Cd induction of the GST Ya promoter–regu-
lated reporter may suggest a cellular response
to protect against oxidative damage. The coor-
dinate dose-related induction of the
NFκBRE–regulated reporter by Cd further
suggests an oxidative damage response
(33,34,53). Cd also produced a moderate
dose-dependent induction of the HSP70 pro-
moter, suggesting a cellular response to protein
damage (29,54–56) and a small dose-related
induction of the immediate early proto
oncogene promoter FOS. Induction of FOS is
in general agreement with other reports indi-
cating Cd induction of immediate early genes
including FOS, c-jun, and c-myc (49,57–59)
and is suggestive of DNA damage (60). As
both protein structural perturbations and
DNA damage may result from oxidative stress,
the induction of the HSP70 and FOS promot-
ers may also relate to a cellular response to
oxidative stress. These combined results sug-
gest that oxidative stress may comprise an
important part of the mechanism of Cd toxic-
ity and carcinogenicity. It is important to note,
however, that this may not be a direct effect of
the metal, as Cd is not chemically redox active.
Finally, the induction of NFκBRE, CYP1A1,
XRE, and GST Ya promoters (Figure 6)
suggests several signal-transduction pathways
for further studies of Cd-mediated effects.
The results observed in testing Cr in these
assays present a very interesting picture. The
uniform lack of response after treatment with
rather high doses up to 500 µM Cr(III)
(Figure 7) is consistent with earlier literature
indicating little toxicity for Cr(III) and sug-
gesting a role for Cr(III) as an essential trace
nutrient [reviewed in Anderson (61)]. In con-
trast, Cr(VI) exposure (Figure 8) produced a
proﬁle of gene expression that differed sharply
from Cr(III) and other metals used in this
study. Differences in the rate of uptake
between Cr(VI) and Cr(III) could possibly
contribute to these observations. Coordinate
dose-related induction of the FOS and
NFκBRE promoters observed with Cr(VI)
was strongly suggestive of cellular responses to
oxidative stress (32–34,53,60) and was consis-
tent with earlier reports (62,63). At the high
dose (10 µM), Cr(VI) induced very strong
expression of the p53RE promoter and more
moderate expression of the GADD45 and
GADD153 promoters. Induction of these
three promoters, along with induction of the
FOS promoter, suggests a cellular response to
DNA damage (39,40,44,45,60,64). Induction
of the HSP70 and GRP78 promoters, which
are both markers of protein structural
perturbations, suggests further responses to
cellular damage (29,43,54–56).
Like As, Cd, and Pb, Cr(VI) induced
expression of the CYP1A1, GST Ya, and
XRE promoter constructs. Although induc-
tion of this set of three promoters is charac-
teristically suggestive of the presence of aryl
hydrocarbons (30,35,36,48) and may be
partly attributable to traces of aryl hydrocar-
bons in the HA carrier, it is important to
note that these three promoters were induced
to a much smaller extent by HA alone (Figure
3) and were not induced at all by Cr(III) in
HA (Figure 7). Thus, it appears that Cr(VI)
directly or indirectly alters the regulation of
CAT gene expression by these three promot-
ers. In contrast to As (Figure 4) and Cd
(Figure 6), Cr(VI) produced only minimal
induction of the metal-responsive hMTIIA
promoter. Last, Cr(VI) induced expression of
the CRE promoter, suggesting the involve-
ment of the cyclic AMP signal-transduction
pathway (65). Although these results conﬁrm
and extend previous reports of Cr(VI)-medi-
ated expression of oxidative stress genes, they
also demonstrate several new signal-transduc-
tion pathways, including p53RE, XRE,
GADD45, CYP1A1, CRE, GADD153,
hMTIIA, and GRP78. These novel pathways
offer potential new insights into the mecha-
nisms of Cr toxicity and carcinogenicity.
When a mixture of Cd(II), Cr(III), and
Pb(II) was tested in the CAT–Tox (L) assays
(Figure 9), hMTIIA was the only promoter
strongly induced in a dose-responsive pattern.
Induction of the metal-responsive hMTIIA
promoter must be primarily attributable to
Cd in the mixture, as it was only moderately
Chemical Mixtures • Mumtaz et al.
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ally unaffected by Cr(III) (Figure 7) (26,27).
The CYP1A1 and XRE promoters were also
marginally induced by this mixture, but these
results were only significant at the highest
dose. Each of these promoters was induced to
a smaller extent after treatment with this mix-
ture of metals than by either Cd(II) (Figure 6)
or Pb(II) (Figure 5) alone. This ﬁnding, along
with the observation that these promoters
were not appreciably induced by Cr(III) alone
(Figure 7), suggests that Cr(III) may actually
offer a protective effect by inhibiting induc-
tion of these promoters by Cd(II) or Pb(II). In
contrast, these results clearly showed no evi-
dence for synergistic activation of gene expres-
sion by the three metals in this mixture.
In summary, the results described
demonstrate that the four high-priority metals
tested in these studies modulate gene expres-
sion through signal-transduction pathways
not previously associated with these metals.
These ﬁndings thus suggest new directions for
future studies into the biochemical mecha-
nisms of toxicity and carcinogenicity of these
metals. Additionally, no evidence was found
for synergistic activation of gene expression
by a mixture of Cd(II), Cr(III), and Pb(II)
tested in this assay.
Results from these types of gene induc-
tion studies can be used to address issues
related to modes of action, dose–response
relationships, chemical interactions, and
human exposure assessment (66). However, it
is important to note that in the cascade of
events that occur in a biologic system, the
chemically induced alterations of gene expres-
sion must lead to qualitative or quantitative
changes in the total protein complement, the
proteome, of cells and tissues. Such changes
in the proteome will likely perturb the home-
ostasis of an organism. Establishing links
between genomics and proteomics is critical
for their use in the toxicology and risk assess-
ment of chemicals and their mixtures.
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